A Pilot Study of Wee1 Inhibition Induction Prior to Tumor Reductive Surgery in Ovarian Cancer

Trial Profile

A Pilot Study of Wee1 Inhibition Induction Prior to Tumor Reductive Surgery in Ovarian Cancer

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 29 Jan 2018

At a glance

  • Drugs AZD-1775 (Primary)
  • Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
  • Focus Pharmacodynamics; Pharmacogenomic
  • Acronyms WEE WIN
  • Most Recent Events

    • 23 Jan 2018 Planned End Date changed from 1 Feb 2019 to 1 Feb 2021.
    • 23 Jan 2018 Planned primary completion date changed from 1 Feb 2019 to 1 Feb 2020.
    • 09 Mar 2017 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top